Deep Learning–Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction

2022/12/20 by David J. Ho, David Joon Ho, Narasimhan P. Agaram +11 · 7 citations
Medicine · Computer Science · Biochemistry, Genetics and Molecular Biology · #Radiomics and Machine Learning in Medical Imaging #AI in cancer detection #Molecular Biology Techniques and Applications

paper · pdf · doi:10.1016/j.ajpath.2022.12.004

Cited by

• Recent Advancements in Deep Learning Using Whole Slide Imaging for Cancer Prognosis. [europepmc]
• Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials. [europepmc]
• Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation. [europepmc]
• End-to-End Deep Learning Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Patients Using Routine MRI. [europepmc]
• A Need for Multi-Institutional Collaboration for Deep Learning-Driven Assessment of Osteosarcoma Treatment Response. [europepmc]
• Non-Coding RNAs in Diagnostic Pathology of High-Grade Central Osteosarcoma. [europepmc]
• AI-Driven Innovations in Neuroradiology and Neurosurgery: Scoping Review of Current Evidence and Future Directions. [europepmc]